4D Molecular Therapeutics IncNASDAQ:FDMT
- LAST PRICE7.9900
- TODAY'S CHANGE (%)-0.4200 (-4.9941%)
- Bid / Lots7.8100/ 1
- Ask / Lots8.2300/ 10
- Open / Previous Close8.4100 / 8.4100
- Day Range
- 52 Week Range
- Volume942,815
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | FDMT |
|---|---|---|
| 09:32 ET | 38352 | 8.4092 |
| 09:33 ET | 11678 | 8.1805 |
| 09:35 ET | 2200 | 8.07 |
| 09:37 ET | 4905 | 8.07 |
| 09:39 ET | 25111 | 8.05 |
| 09:42 ET | 4255 | 8 |
| 09:44 ET | 1651 | 8 |
| 09:46 ET | 4075 | 8.01 |
| 09:48 ET | 18275 | 8 |
| 09:50 ET | 7705 | 8 |
| 09:51 ET | 2875 | 8 |
| 09:53 ET | 1492 | 7.99 |
| 09:55 ET | 6783 | 7.88 |
| 09:57 ET | 2088 | 7.87 |
| 10:00 ET | 4666 | 7.89 |
| 10:02 ET | 600 | 7.85 |
| 10:04 ET | 2510 | 7.865 |
| 10:06 ET | 1121 | 7.855 |
| 10:08 ET | 2377 | 7.855 |
| 10:09 ET | 2114 | 7.89 |
| 10:11 ET | 2754 | 7.95 |
| 10:13 ET | 1400 | 7.98 |
| 10:15 ET | 2102 | 8.0256 |
| 10:18 ET | 587 | 8 |
| 10:20 ET | 816 | 8.02 |
| 10:22 ET | 3197 | 8.075 |
| 10:24 ET | 495 | 8.0316 |
| 10:26 ET | 200 | 8.04 |
| 10:27 ET | 525 | 8.0171 |
| 10:29 ET | 300 | 8.04 |
| 10:31 ET | 1230 | 8.01 |
| 10:33 ET | 648 | 8.03 |
| 10:36 ET | 210 | 8.06 |
| 10:38 ET | 1000 | 8.1075 |
| 10:40 ET | 100 | 8.085 |
| 10:42 ET | 1262 | 8.03 |
| 10:44 ET | 100 | 8.06 |
| 10:45 ET | 800 | 8.065 |
| 10:47 ET | 200 | 8.03 |
| 10:49 ET | 500 | 8.02 |
| 10:51 ET | 1840 | 7.9901 |
| 10:54 ET | 2204 | 8.07 |
| 10:56 ET | 400 | 8.1 |
| 11:00 ET | 900 | 8.09 |
| 11:03 ET | 600 | 8.05 |
| 11:05 ET | 200 | 8.02 |
| 11:07 ET | 3143 | 8.02 |
| 11:09 ET | 3905 | 8.06 |
| 11:12 ET | 1000 | 8.11 |
| 11:14 ET | 1200 | 8.16 |
| 11:16 ET | 3724 | 8.19 |
| 11:18 ET | 2400 | 8.2 |
| 11:20 ET | 10663 | 8.14 |
| 11:21 ET | 1298 | 8.12 |
| 11:23 ET | 9866 | 8.16 |
| 11:25 ET | 1072 | 8.16 |
| 11:27 ET | 211 | 8.18 |
| 11:30 ET | 2650 | 8.21 |
| 11:34 ET | 2264 | 8.205 |
| 11:36 ET | 5332 | 8.21 |
| 11:38 ET | 1000 | 8.19 |
| 11:39 ET | 300 | 8.13 |
| 11:41 ET | 1932 | 8.19 |
| 11:43 ET | 10699 | 8.165 |
| 11:45 ET | 1174 | 8.16 |
| 11:48 ET | 900 | 8.15 |
| 11:50 ET | 3100 | 8.14 |
| 11:52 ET | 27511 | 8.13 |
| 11:54 ET | 2400 | 8.16 |
| 11:56 ET | 1279 | 8.17 |
| 11:57 ET | 100 | 8.16 |
| 11:59 ET | 582 | 8.17 |
| 12:01 ET | 2932 | 8.18 |
| 12:03 ET | 300 | 8.1351 |
| 12:06 ET | 200 | 8.17 |
| 12:08 ET | 29913 | 8.085 |
| 12:10 ET | 2196 | 8.04 |
| 12:14 ET | 5996 | 7.945 |
| 12:15 ET | 1782 | 7.86 |
| 12:17 ET | 4770 | 7.91 |
| 12:19 ET | 800 | 7.9229 |
| 12:21 ET | 300 | 7.92 |
| 12:24 ET | 3830 | 7.89 |
| 12:26 ET | 4544 | 7.88 |
| 12:28 ET | 700 | 7.87 |
| 12:30 ET | 9362 | 7.834 |
| 12:32 ET | 1300 | 7.9 |
| 12:33 ET | 1350 | 7.88 |
| 12:37 ET | 1800 | 7.8669 |
| 12:39 ET | 1027 | 7.885 |
| 12:42 ET | 948 | 7.91 |
| 12:44 ET | 1200 | 7.89 |
| 12:46 ET | 506 | 7.91 |
| 12:48 ET | 800 | 7.93 |
| 12:50 ET | 1100 | 7.925 |
| 12:51 ET | 3880 | 7.91 |
| 12:53 ET | 3818 | 7.97 |
| 12:55 ET | 300 | 7.94 |
| 12:57 ET | 1300 | 7.96 |
| 01:00 ET | 1746 | 7.96 |
| 01:02 ET | 1100 | 7.93 |
| 01:04 ET | 651 | 7.96 |
| 01:06 ET | 200 | 7.965 |
| 01:08 ET | 1847 | 7.93 |
| 01:09 ET | 100 | 7.925 |
| 01:11 ET | 400 | 7.94 |
| 01:13 ET | 2836 | 7.93 |
| 01:15 ET | 3625 | 7.93 |
| 01:18 ET | 1836 | 7.91 |
| 01:20 ET | 2700 | 7.92 |
| 01:22 ET | 400 | 7.9399 |
| 01:24 ET | 1040 | 7.93 |
| 01:26 ET | 3798 | 7.89 |
| 01:27 ET | 2963 | 7.92 |
| 01:29 ET | 2691 | 7.8906 |
| 01:31 ET | 1119 | 7.925 |
| 01:33 ET | 4696 | 8 |
| 01:36 ET | 1630 | 7.97 |
| 01:40 ET | 300 | 7.975 |
| 01:42 ET | 200 | 7.975 |
| 01:45 ET | 1076 | 7.9697 |
| 01:47 ET | 100 | 7.97 |
| 01:49 ET | 4617 | 7.95 |
| 01:51 ET | 100 | 7.95 |
| 01:54 ET | 3321 | 7.92 |
| 01:56 ET | 2100 | 7.92 |
| 01:58 ET | 2732 | 7.93 |
| 02:00 ET | 400 | 7.92 |
| 02:02 ET | 3053 | 7.94 |
| 02:05 ET | 300 | 7.94 |
| 02:07 ET | 7198 | 7.95 |
| 02:09 ET | 3327 | 7.9828 |
| 02:12 ET | 1995 | 7.975 |
| 02:16 ET | 300 | 7.98 |
| 02:18 ET | 1533 | 7.98 |
| 02:20 ET | 1097 | 7.985 |
| 02:21 ET | 5080 | 8.0065 |
| 02:25 ET | 7499 | 8.02 |
| 02:30 ET | 3510 | 8.01 |
| 02:34 ET | 100 | 8.01 |
| 02:36 ET | 100 | 8.025 |
| 02:38 ET | 1590 | 8 |
| 02:39 ET | 2206 | 8 |
| 02:41 ET | 296 | 8 |
| 02:43 ET | 404 | 7.99 |
| 02:45 ET | 200 | 7.99 |
| 02:48 ET | 300 | 8 |
| 02:50 ET | 5839 | 7.99 |
| 02:52 ET | 12217 | 7.96 |
| 02:54 ET | 12501 | 7.95 |
| 02:56 ET | 600 | 7.96 |
| 02:57 ET | 1121 | 7.91 |
| 02:59 ET | 8102 | 7.98 |
| 03:01 ET | 1953 | 7.98 |
| 03:03 ET | 2300 | 8 |
| 03:06 ET | 61325 | 8 |
| 03:08 ET | 420 | 7.99 |
| 03:10 ET | 2000 | 8 |
| 03:12 ET | 710 | 7.98 |
| 03:14 ET | 514 | 7.95 |
| 03:15 ET | 1217 | 7.945 |
| 03:17 ET | 6088 | 8.035 |
| 03:19 ET | 100 | 8.035 |
| 03:21 ET | 3826 | 8.08 |
| 03:24 ET | 100 | 8.05 |
| 03:26 ET | 3367 | 8.085 |
| 03:28 ET | 3886 | 8.055 |
| 03:30 ET | 1024 | 8.05 |
| 03:32 ET | 1695 | 8.015 |
| 03:33 ET | 1838 | 8.015 |
| 03:35 ET | 400 | 8.03 |
| 03:37 ET | 450 | 8 |
| 03:39 ET | 1755 | 8.01 |
| 03:42 ET | 200 | 8.02 |
| 03:44 ET | 2072 | 8.0193 |
| 03:46 ET | 1603 | 8.01 |
| 03:48 ET | 1274 | 8.015 |
| 03:50 ET | 3320 | 8.0195 |
| 03:51 ET | 3004 | 7.98 |
| 03:53 ET | 600 | 7.98 |
| 03:55 ET | 7923 | 8.02 |
| 03:57 ET | 4042 | 8.01 |
| 04:00 ET | 182327 | 7.99 |
Yesterday
Nov 14, 2024
DJ 4D Molecular Therapeutics Is Maintained at Buy by Chardan Capital, from 4:54PM ET on Thursday Nov 14, 2024 by Dow Jones
4:54PM ET on Thursday Nov 14, 2024 by Dow JonesDJ 4D Molecular Therapeutics Price Target Maintained With a $36.00/Share by HC Wainwright & Co., from 1:41PM ET on Thursday Nov 14, 2024 by Dow Jones
1:41PM ET on Thursday Nov 14, 2024 by Dow JonesDJ 4D Molecular Therapeutics Is Maintained at Outperform by RBC Capital, from 12:04PM ET on Thursday Nov 14, 2024 by Dow Jones
12:04PM ET on Thursday Nov 14, 2024 by Dow Jones4DMT to Participate in Upcoming Investor Conferences and Ophthalmology Innovation Summit XIV, from 8:00AM ET on Thursday Nov 14, 2024 by Dow Jones
8:00AM ET on Thursday Nov 14, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
4D Molecular Therapeutics Inc | 437.1M | -2.9x | --- |
Cartesian Therapeutics Inc | 430.5M | -0.4x | --- |
MeiraGTx Holdings PLC | 449.2M | -4.6x | --- |
Taysha Gene Therapies Inc | 411.9M | -34.9x | --- |
Foghorn Therapeutics Inc. | 437.0M | -4.0x | --- |
ProQR Therapeutics NV | 388.7M | -11.7x | --- |
Company Information
4D Molecular Therapeutics, Inc. is a clinical-stage genetic medicines company focused on unlocking the full potential of genetic medicines to treat diseases in ophthalmology and pulmonology. The Company has a portfolio of genetic medicine product candidates, with five product candidates in clinical trials in seven patient populations: 4D-150 for the treatment of wet age-related macular degeneration (wet AMD) and diabetic macular edema (DME), 4D-710 for the treatment of cystic fibrosis lung disease (both in modulator ineligible and eligible populations), 4D-310 for the treatment of Fabry disease cardiomyopathy, 4D-125 for the treatment of X-linked retinitis pigmentosa (XLRP), and 4D-110 for the treatment of choroideremia. In addition, it has two product candidates in preclinical development: 4D-175 for geographic atrophy (GA) and 4D-725 for alpha-1 antitrypsin deficiency lung disease.
Contact Information
- Headquarters
- 5858 Horton Street #455, EmeryvilleEMERYVILLE, CA, United States 94608
- Phone
- 510-505-2680
- Fax
- 302-655-5049
Executives
- Executive Chairman of the Board
- John Milligan
- President, Chief Operating Officer
- Fariborz Kamal
- Chief Executive Officer, Co-Founder, Director
- David Kirn
- Chief Financial and Business Officer
- Uneek Mehra
- Chief Medical Officer
- Robert Kim
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $415.2M |
|---|---|
Revenue (TTM) | $18.0K |
Shares Outstanding | 52.0M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 2.77 |
EPS | $-2.76 |
Book Value | $7.15 |
P/E Ratio | -2.9x |
Price/Sales (TTM) | 23,068.7 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -935,416.70% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
